In addition, the SEC filing also addressed what would happen if the deal fell through all together. The merger agreement between Aetna and Humana states that if the deal is terminated under specified circumstances, including the termination by either party upon the other party’s change of recommendation or material breach of its “no shop” obligations, Aetna would be required to pay Humana a termination fee of $1.69 billion, and Humana would be required to pay Aetna a $1.31 billion termination fee.
Although it is anticipated the deal will face antitrust scrutiny, Aetna Chairman and CEO Mark Bertolini is confident the acquisition will pass antitrust review.
More articles on payer issues:
Humana cuts profit outlook after Aetna deal announcement
Aetna CEO claims Louisville jobs may grow
Aetna inks $37B deal to acquire Humana: 5 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
